“Iceland Inc.”?: On the ethics of commercial population genomics
- Social Science & Medicine
Author/s: -Merz, Jon F. -McGee, Glenn E. -Sankar, PamelaJournal: Social Science & Medicine
Year: 2004
Volume: 58
Issue: 6
Pages: 1201-1209
A detailed analysis of the Icelandic commercial population-wide genomics database project of deCODE Genetics was performed for the purpose of providing ethics insights into public/private efforts to develop genetic databases. This analysis examines the moral differences between the general case of governmental collection of medical data for public health purposes and the centralized collection planned in Iceland. Both the process of developing the database and its design vary in significant ways from typical government data collection and analysis activities. Because of these differences, the database may serve the interests of deCODE more than it serves the interests of the public, undermining the claim that presumed consent for this data collection and its proprietary use is ethical. We believe that there is an evolving consensus that informed consent of participants must be secured for population-based genetics databases and research. The Iceland model provides an informative counterexample that holds key ethics lessons for similar ventures.
Related Posts
-
ELSI challenges and strategies of national biobank infrastructures
No Comments | Mar 14, 2014 -
Development of stem cells from umbilical cord blood and blood banking:” Non-controversial” and” free of political and ethical debate”?
No Comments | Mar 14, 2014 -
Tailoring the Process of Informed Consent in Genetic and Genomic Research
No Comments | Mar 14, 2014 -
Code of Practice 1: Consent
No Comments | Mar 14, 2014